"Grunberger Diabetes Institute (GDI) provides comprehensive patient evaluation and treatment of diabetes and diabetes-related conditions for patients living throughout Southeastern Michigan and beyond. We also specialize in the diagnosis and treatment of such common endocrine and metabolic conditions as thyroid, pituitary, adrenal and gonadal diseases, osteoporosis, high blood pressure, and abnormal cholesterol. The Institute is unique in uniting sophisticated diabetes management and education with an opportunity to participate in our weight management program, all under one roof with the same team of experienced professionals."

During the past decade, Grunberger Diabetes Institute conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Grunberger Diabetes Institute" #1 sponsor was "AstraZeneca" with 3 trials, followed by "Medtronic Diabetes" with 3 trials sponsored, "Axio Research. LLC" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Valeritas, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Grunberger Diabetes Institute" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Insulet Corporation" with 1 trials as a collaborator, "Integrated Medical Development" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Grunberger Diabetes Institute" are "Type 2 Diabetes Mellitus" (3 trials), "Diabetes" (2 trials), "Atherosclerosis" (1 trials), "Cardiovascular Diseases" (1 trials) and "Cerebrovascular Accident" (1 trials). Many other conditions were trialed in "Grunberger Diabetes Institute" in a lesser frequency.

Most popular intervention types in "Grunberger Diabetes Institute" are "Drug" (5 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "AC2993" (3 trials), "Placebo" (2 trials), "670G and 770G Insulin Pump" (1 trials), "Extended Infusion Set" (1 trials) and "Extended release niacin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Grunberger Diabetes Institute" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Grunberger Diabetes Institute". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Grunberger Diabetes Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Grunberger Diabetes Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".